Baseline ACF number | 0.38^{a} |

*N* | 19 | 20 | 39 | |

Mean (SD) | 12.2 (6.8) | 11.5 (10.6) | 11.8 (8.8) | |

Median | 9.0 | 8.0 | 9.0 | |

Range | (5.0–28.0) | (5.0–52.0) | (5.0–52.0) | |

6-month ACF number | 0.25^{a} |

*N* | 15 | 17 | 32 | |

Mean (SD) | 12.7 (10.01) | 11.5 (12.3) | 12.1 (11.2) | |

Median | 10.0 | 8.0 | 9.0 | |

Range | (2.0–44.0) | (2.0–53.0) | (2.0–53.0) | |

ACF number percent change | 0.28^{a}^{,}^{b} |

*N* | 15 | 17 | 32 | |

Mean (SD) | 3.7 (49.1) | 0 (52.7) | 1.7 (55.9) | |

Median | 0.0 | 0.0 | 0.0 | |

ACF size percent change | 0.83^{a} |

*N* | 15 | 16 | 31 | |

Mean (SD) | 10.3 (61.1) | 12.6 (102.8) | 11.5 (83.9) | |

Median | 0.0 | 0.0 | 0.0 | |

Adenoma recurrence | 0.69^{c} |

Missing | 5 | 3 | 8 | |

No | 10 (71.4%) | 11 (64.75%) | 21 (67.7%) | |

Yes | 4 (28.6%) | 6 (35.3%) | 10 (32.3%) | |

Adenoma recurrence (≥5 mm) | 0.36^{c} |

Missing | 5 | 3 | 8 | |

No | 14 (100.0%) | 16 (94.1%) | 30 (96.8%) | |

Yes | 0 (0.0%) | 1 (5.9%) | 1 (3.2%) | |

Percent total dose received | 0.14^{a} |

*N* | 19 | 20 | 39 | |

Mean (SD) | 83.2 (29.3) | 91.7 (24.0) | 87.6 (26.7) | |